The Medical Letter on Drugs and Therapeutics
November 22, 1996
|Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article.|
November 22, 1996 (Issue: 988)Use of alendronate (Fosamax), estrogen and other drugs for prevention and treatment of osteoporosis (Medical Letter, 38:1, 1996) has been accompanied by widespread availability of bone density screening tests, not only in doctors offices and ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.